ALLK
Price
$1.05
Change
-$0.01 (-0.94%)
Updated
Apr 23, 6:59 PM EST
13 days until earnings call
SANA
Price
$8.10
Change
+$0.17 (+2.14%)
Updated
Apr 23, 6:59 PM EST
13 days until earnings call
Ad is loading...

Compare predictions ALLK vs SANA

Header iconALLK vs SANA Comparison
Open Charts ALLK vs SANABanner chart's image
Allakos
Price$1.05
Change-$0.01 (-0.94%)
Volume$175.6K
CapitalizationN/A
Sana Biotechnology
Price$8.10
Change+$0.17 (+2.14%)
Volume$1.07M
CapitalizationN/A
View a ticker or compare two or three
ALLK vs SANA Comparison Chart

Loading...

ALLKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SANADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALLK vs. SANA commentary
Apr 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLK is a Hold and SANA is a Hold.

COMPARISON
Comparison
Apr 24, 2024
Stock price -- (ALLK: $1.06 vs. SANA: $7.93)
Brand notoriety: ALLK and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLK: 48% vs. SANA: 114%
Market capitalization -- ALLK: $92.27M vs. SANA: $1.78B
ALLK [@Biotechnology] is valued at $92.27M. SANA’s [@Biotechnology] market capitalization is $1.78B. The market cap for tickers in the [@Biotechnology] industry ranges from $557.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLK’s FA Score shows that 1 FA rating(s) are green whileSANA’s FA Score has 0 green FA rating(s).

  • ALLK’s FA Score: 1 green, 4 red.
  • SANA’s FA Score: 0 green, 5 red.
According to our system of comparison, SANA is a better buy in the long-term than ALLK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLK’s TA Score shows that 2 TA indicator(s) are bullish while SANA’s TA Score has 3 bullish TA indicator(s).

  • ALLK’s TA Score: 2 bullish, 4 bearish.
  • SANA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, SANA is a better buy in the short-term than ALLK.

Price Growth

ALLK (@Biotechnology) experienced а -1.85% price change this week, while SANA (@Biotechnology) price change was -7.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.03%. For the same industry, the average monthly price growth was +4.97%, and the average quarterly price growth was +1257.50%.

Reported Earning Dates

ALLK is expected to report earnings on Aug 05, 2024.

SANA is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (+10.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALLK with price predictions.
OPEN
A.I.dvisor published
a Summary for SANA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SANA($1.78B) has a higher market cap than ALLK($92.3M). SANA YTD gains are higher at: 94.363 vs. ALLK (-61.172).
ALLKSANAALLK / SANA
Capitalization92.3M1.78B5%
EBITDAN/AN/A-
Gain YTD-61.17294.363-65%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
ALLKSANA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 28 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
ALLKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SANADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STKXF0.06N/A
+6.19%
StrikePoint Gold
KAOOY8.300.21
+2.60%
Kao Corp
ALYAF1.480.01
+0.34%
Alithya Group
PRNDY30.940.07
+0.23%
PERNOD RICARD S A American Depositary Receipts - Sponsored
NDBKY11.400.02
+0.20%
Nedbank Group Limited

ALLK and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLK has been loosely correlated with AXON. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLK jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLK
1D Price
Change %
ALLK100%
-0.93%
AXON - ALLK
38%
Loosely correlated
+0.07%
PRME - ALLK
35%
Loosely correlated
+5.99%
VIR - ALLK
34%
Loosely correlated
+1.89%
OCUL - ALLK
33%
Loosely correlated
-2.78%
AKRO - ALLK
33%
Loosely correlated
+0.14%
More

SANA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SANA has been loosely correlated with BEAM. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SANA jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SANA
1D Price
Change %
SANA100%
+4.20%
BEAM - SANA
52%
Loosely correlated
+0.84%
NTLA - SANA
51%
Loosely correlated
+1.21%
CRSP - SANA
47%
Loosely correlated
+1.11%
EDIT - SANA
45%
Loosely correlated
+2.00%
AXON - SANA
43%
Loosely correlated
+0.07%
More